Exchange: PRIVATE·

UROVUrovant Sciences Ltd.

$0.00
$0.00
(0.00%)
Today
Mkt Cap$531.75M
Vol1.74M

About

Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Its pipeline includes Vibegron (RVT-901) and URO-902. The company was founded on January 27, 2016 and is headquartered in London, the United Kingdom.

Latest UROV News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.